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Cutaneous leukocytoclastic vasculitis is characterized
by the deposition of circulating immune complexes,
neutrophil extravasation, and vessel destruction, but
mechanisms of circulating immune complexes capture
within postcapillary venules are unknown. We demon-
strate that circulating immune complexes from sera
of vasculitis patients bind to cultured endothelium
in an Fc gamma receptor IIa-dependent fashion. In
lesional skin, endothelial cells bind immunoglobulin
G2 > immunoglobulin G3 and immunoglobulin G4,
but not immunoglobulin G1, even before obvious
neutrophil transmigration and vessel damage. As the
human Fc gamma receptor IIa proteins exist in two
allotypes (one with a histidine at position 131, which
binds immunoglobulin G1, 2, 3 and the other with an
arginine at position 131, which binds immunoglobulin
G1, and 3, but is unable to bind immunoglobulin G2),
we expected an altered prevalence of histidine 131
forms in vasculitis patients. Sequence analysis, how-
ever, revealed an equal distribution of allotypes in
Leukocytoclastic vasculitis (LV) is an immune complexdisorder in which there is segmental inflammation withleukocytes and fibrinoid necrosis of the blood vessels. Tounderstand mechanisms of immune complex-mediatedtissue damage, Arthus reaction has been frequently used
as a model for LV. The Arthus reaction occurs upon the injection
of an antigen into a sensitized host and shows vascular deposits of
antigen–antibody complexes followed by leukocyte infiltration,
leukocytoclasia, and vascular damage (Cochrane, 1967). In a
beautiful series of experiments Sylvestre and Ravetch demonstrated
that this immune complex-induced inflammatory reaction critically
depends on Fc gamma receptors (FcγR); whereas wild-type mice
as well as decomplemented mice developed Arthus reaction upon
antigenic challenge, hemorrhagic papules and vascular damage were
absent in FcγR knockout mice (Sylvestre and Ravetch, 1994),
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patients and controls. In conclusion, circulating
immune complex binding to endothelial Fc gamma
receptor IIa is among the initial steps in the develop-
ment of vasculitis. Although immunoglobulin G2 is
the predominant subtype precipitated at endothelial
surfaces, it is not required for fixing circulating
immune complexes to endothelium, because patients
homozygote for Fc gamma receptor IIa–arginine 131
equally develop leukocytoclastic vasculitis as those
bearing the Fc gamma receptor IIa–histidine 131 allele.
As immunoglobulin G1 is virtually absent in
leukocytoclastic vasculitis lesions and immunoglobulin
G4 does not bind to both Fc gamma receptor IIa alleles,
these complexes, in addition to immunoglobulin G2,
should contain immunoglobulin G3 in order to fix to
vascular Fc gamma receptor IIa, at least in persons
homozygous for Fc gamma receptor IIa–arginine 131.
Keywords: CD32/immunoglobulin G subtypes/leukocyto-
clastic vasculitis/microvessels. J Invest Dermatol 113:56–
60, 1999
clearly emphasizing the importance of FcγR in the initiation of
immune complex-induced tissue damage.
FcγR are broadly expressed on cells of the hematopoietic lineage.
They mediate phagocytosis of immunoglobulin (Ig)G-opsonized
particles. Specifically, the low-affinity FcγR, FcγRII (CD32), and
FcγRIII (CD16), become activated after cross-linking by immune
complexes and initiate a sequence of events ultimately resulting in
an inflammatory reaction (Ravetch, 1994; Clynes and Ravetch,
1995; Deo et al, 1997; Lowry et al, 1998). Endothelial cells express
FcγRII but not FcγRIII. Among the three FcγRII splice variants,
FcγRIIa, b, and c, microvessels have FcγRIIa only (Gro¨ger et al,
1996). Microvessels share this unique FcγR expression profile only
with the platelets (Indik et al, 1991). Interestingly, heparin-induced
thrombocytopenia is mediated by a heparin-dependent antibody/
platelet factor 4/heparin complex, which binds to platelets by way
of FcγRIIa (Burgess et al, 1995). We, therefore, wished to explore
the possibility that immune complexes in patients with cutaneous
LV use the endothelial FcγRIIa in order to fix to the vessel wall.
MATERIALS AND METHODS
Patient characteristics Patients were selected on basis of: (i) the clinical
and histopathologic picture establishing the diagnosis of LV; (ii) a history
of a preceding infection (period of fever, fatigue, and malaise) prior to
the onset of palpable purpura lesions restricted to the lower extremities;
VOL. 113, NO. 1 JULY 1999 ENDOTHELIAL FCγRIIa IN VASCULITIS PATIENTS 57
(iii) detectable circulating immune complexes (CIC) within the serum (by
the routinely performed C1q-binding assay); (iv) the absence of IgA
deposits within the vessel wall of lesional skin as detected by routine direct
immunofluorescence on frozen tissue samples; and (v) negative anti-nuclear
antibodies and rheumatoid factors. No patient had detectable hematuria,
arthritis, or abdominal manifestations.
Sera, collected between days 2 and 5 after the onset of cutaneous lesions
were analyzed from 20 patients after obtaining informed consent. Sera
samples were either directly used for indirect immunofluorescence and
western blot as described below or IgG fractions were purified by
Immunopure IgG Preparation Kit (Pierce, Rockford, IL 61105) and used
accordingly. In selected experiments, F(ab)2 fragments were prepared by
Immunopure IgG Fab and F(ab)2 Preparation Kit according to the
instruction provided by the manufacturer (Pierce). Purity of the resulting
F(ab)2 fragments was tested by electrophoresis.
Indirect immunofluorescence Dermal microvascular endothelial cells
were isolated from thigh skin of cadaveric donors and subcultivated as
described (Gro¨ger et al, 1996) and used at passages 2–3. For indirect
immunofluorescence, endothelial cells were placed on adhesion slides
(BioRad Laboratories, Hercules, CA), fixed with acetone/methanol at
–20°C for 15 min, air dried, and incubated with patients sera for 45 min.
After rinsing in phosphate-buffered saline (PBS), bound IgG was visualized
by a rabbit anti-human IgG labeled with fluorescein isothiocyanate (Pharm-
ingen, Uppsala, Sweden). For blocking experiments, cells were preincubated
with an anti-FcγRII Fab fragment (2 µg per ml, clone IV.3, Medarex Inc.,
West Lebanon, NH) for 30 min prior to the addition of patients’ sera.
After mounting with Fluoprep Mounting Medium (BioMerieux, Marcy
L’Etoile, France), cells examined by a laser scan microscope (LSM 410,
Zeiss, Oberkochen, Germany).
Western blotting 3T6 cells transfected with either FcγRIIa–R131 or
FcγRIIa–H131 were a kind gift from Nomdo A.C. Westerdaal (Department
of Immunology, University of Hospital Utrecht, The Netherlands). Cells
were grown in RPMI supplemented with 10% fetal calf serum (Life
Technology, Paisley, U.K.). 3T6 cells were collected by centrifugation, the
resulting cell pellet was lysed and loaded on to 10% sodium dodecyl sulfate
gels as described (Matsumura et al, 1997). After blotting, membranes were
incubated in PBS containing 1% low fat milk (BioRad Laboratories,
Hercules, CA) for 12 h, followed by incubation with purified IgG or
F(ab)2 fragments derived from patients serum or from healthy control
serum. For detection, a rabbit–anti-human IgG horseradish peroxidase-
labeled second step antibody (Jackson, West Grove, PA; diluted 1:100)
was used and visualized by chemiluminescence (ECL-system, Amersham,
Arlington Heights, IL).
Immunohistochemistry of lesional skin Routinely fixed and paraffin-
embedded skin specimens from vasculitis lesions (n 5 15; age of lesions
, 7 d) and from healthy control skin (n 5 8) were cut into 8 µm sections,
deparaffinized using serial dilutions of C2H5OH, dried at 60°C for 24 h,
rehydrated and incubated with 0.03 g protease (Sigma, St. Louis, MO;
type XXIV bacterial) in 100 ml PBS for 10 min at 37°C. After rinsing in
PBS, sections were placed in 0.3% H2O2 in PBS for 10 min at room
temperature. Then, a routine three-step immunohistochemistry was per-
formed as described previously (Kunstfeld et al, 1997). First step antibodies
were anti-human IgG1, anti-human IgG2, anti-human IgG3, and anti-
human IgG4 (all Zymed Laboratories, San Francisco, CA) and an isotype
control antibody. Second step antibodies and the ABC kit were from
Vector Laboratories (Burlingame, CA). Peroxidase was visualized with 3-
amino-9-ethylcarbazole (Sigma) and sections were counterstained with
hematoxylin. Numbers of positively stained vessels within the papillary
dermis were counted by three independent observers in two sections per
specimen (four high power fields per section). For each specimen, the total
numbers of positively counted vessels were summarized and divided by
the total numbers of high power fields evaluated. (Variation between
observers was below 7%.)
Genotyping of CD32 alleles Genomic DNA was prepared from
peripheral blood cells of 18 patients with LV and of 67 healthy controls
without history of vasculitis as described previously (Miller et al, 1988).
Parts of intron 3 and exon 4 of the FcγRIIa gene were amplified by PCR.
The PCR mixture contained 200 ng genomic DNA, the primers 59CCT
TGG AAT CTA TCC TTA CAA C-39 and 59-ATG AGA ACA GCG
TGT AGC C-39, 1.5 mM MgCl2, 50 mM KCl, 10 mM Tris pH 8.3,
0.2 mM deoxynucleoside triphosphate (Boehringer Mannheim), and 1 U
Taq polymerase (AmpliTaq, Perkin Elmer) in a final volume of 50 µM.
After an initial denaturation at 92°C for 2 min, samples were cycled 35
times (denaturation at 96°C for 15 s, annealing at 57°C for 30 s and
extension at 72°C for 20 s). After each cycle, the annealing temperature
was decreased for 0.3°C and the extension time extended by 1 s. The
calculated size of amplification product was 278 bp and comprised the
polymorphic position 519 encoding the histidine or arginine residue 133
in the mature FcγRIIa protein. The correct sizes of the PCR products
were confirmed by agarose gel electrophoresis, ethidium bromide staining
and visualization by ultraviolet light. Forty microliters of the PCR product
was then precipitated, resuspended, and used as a template for cycle
sequencing. Both strands of the amplification product were sequenced
with labeled terminators (ABI Prismo Ready Dye Terminator Cycle
Sequencing Ready Reaction Kit, Perkin Elmer) according to the manufac-
turers’ instruction. Sequencing primers were the same as used for PCR.
The sequencing products were then precipitated, resuspended in 4 µl
loading buffer and loaded on to a sequencing device (ABI 373A Sequencer,
Perkin Elmer) and electrophoresed for 6 h. Data collection, gel analysis,
and base calling were performed by the sequencing software 373 DNA
Sequencer Collection and Analysis Program 1.2.1. (ABI). In addition, all
sequences were edited by hand.
RESULTS AND DISCUSSION
Endothelial cells in culture bind CIC by way of FcgRII
Endothelial cells incubated with sera from vasculitis patients showed
a distinct membrane staining, which was blocked to background
by preincubation with the Fab fragment of monoclonal antibody
(MoAb) IV.3 (anti-FcγRII) (Fig 1, two representative examples of
a total of 20 patients tested). In contrast, sera of healthy controls
gave a diffuse background staining, which was not affected by
preincubation with MoAb IV.3 Fab (Fig 1). This experiment
demonstrates that sera of LV patients contain IgG, which bind to
endothelial cells in an FcγRII-dependent fashion.
Indirect immunohistochemistry does not allow to distinguish
between an Fc-dependent or an F(ab)2-dependent binding of IgG
to endothelial surfaces. Moreover, the FcγRIIa gene exists in two
different allelic forms, which are due to a point mutation. The
resulting 40 kDa protein has either a histidine (H131) or an arginine
(R131) at position 131 (Parren et al, 1992). As we did not test our
endothelial cells for their FcγRIIa genotype and in order to prove
Fc-dependent binding, we took advantage of 3T6 cells (mouse
fibroblasts) transfected with either human FcγRIIa–H131 or
FcγRIIa–R131. Purified IgG or F(ab)2 fragments from sera of vascul-
itis patients or controls were incubated with blotted FcγRIIa–131 or
FcγRIIa–H131 protein derived from the respective transfectants.
Whereas purified full IgG from LV patients bound to both allelic
forms of FcγRIIa (Fig 2, data shown for R131 only), no binding was
seen when F(ab)2 fragments were used, confirming an Fc-dependent
binding of IgG. Appropriate positive (autoantibodies) and negative
controls confirmed the specificity of the observed bands (Fig 2).
IgG2 is predominant IgG bound to the luminal surface of
microvascular endothelial cells IgG2 is the predominant IgG
subtype used for the neutralization of bacterial antigens (Bredius
et al, 1993; Sanders et al, 1995). As epidemiologic data point
towards an important role of bacterial infections for the development
of LV (McCoombs, 1965; Ekenstam and Callen, 1984; Bonnefoy
and Claudy, 1988), we postulated that IgG2 would be the predomin-
ant IgG subtype deposited within the vessel wall of vasculitis lesions.
Having selected patients with a history of infection preceding the
eruption of LV, we found IgG1 virtually absent, IgG2 deposition
was predominant followed by IgG3 and IgG4 (Fig 3). Vascular
IgM deposits, analyzed for comparison, were found in lesional skin
of six patients only, the remaining nine were negative for IgM
(data not shown). It should be noted that immunohistochemistry
does not allow to quantitate staining intensity. The herein used
approach to count the numbers of positive vessels per high power
field is based on the assumption that the threshold for visual
detection of IgG is roughly the same for all IgG subclasses. As
antibody concentrations were carefully titrated for maximal staining
and all stainings were performed in parallel, the conclusion that
IgG2 is quantitatively the predominant IgG subtype deposited
within the vessel wall appears justified. Moreover, these experiments
allowed to correlate the site of IgG deposition with the degree of
58 GRO¨GER ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 1. Immune complexes bind to cultured endothelium in a
FcgRIIa-dependent fashion. By indirect immunofluorescence, IgG from
sera of LV patients binds to the cellular surfaces of cultured dermal
endothelial cells (a, b; two representative examples shown of 20 different
LV sera tested), which is blocked to background by preincubation with
MoAb IV.3 (anti-FcγRII; c, d). Serum from healthy controls shows
background staining (e), which is not affected by preincubation with MoAb
IV.3 (f).
vascular damage. Most interestingly, IgG deposits were always
restricted to the luminal surfaces of vessels, which, by morphology,
were intact (Fig 4a). Once neutrophils became detectable, IgG
was condensed at the contact site between endothelium and the
neutrophil (Fig 4b). Not before endothelial cells lose cell–cell
contacts and round up, IgG was found at the abluminal site of the
vessel (Fig 4e). These light microscopic observations clearly define
IgG deposition as the earliest detectable alteration of the vessel wall
and point towards a major part for IgG2. As the ability of a cell to
bind IgG2-opsonized bacterial antigens strongly depends on the
allelic polymorphism of FcγRIIa (Sanders et al, 1995), we deter-
mined the FcγRIIa genotype in LV patients as compared with
controls.
Frequencies of FcgRIIa–R131 and FcgR-H131 allotypes in
LV patients equals that of controls Two allelic forms of
FcγRIIa exist, FcγRIIa–R131, which binds IgG3 . 1, but is unable
to bind IgG2 and FcγRIIa–H131, which binds IgG3 . 2 5 1.
Both forms do not bind IgG4 (Parren et al, 1992). The importance
of the allelic polymorphism is underscored by the finding that
Figure 2. Immune complexes bind to FcgRIIa by their Fc portion.
Western blot employing lysates from FcγRIIa–R131-transfected 3T6 cells;
purified IgG (lane 4), but not F(ab)2 fragments (lane 5) from sera of LV
patients bind to the 40 kDa protein FcγRIIa. The identity of the 40 kDa
protein as being FcγRIIa was confirmed by using MoAb IV.3 (anti-FcγRII;
lane 1). As a positive control, we used autoantibodies against FcγRIIa
derived from a patient with systemic lupus, which bind to the 40 kDa
protein, even when F(ab)2 fractions are used (lanes 6 and 7). As a negative
control, we used IgG from healthy controls, which show negligible binding
to the 40 kDa protein (lanes 2 and 3).
Figure 3. IgG2 is the predominant IgG subtype in vasculitis lesions.
Composition of IgG deposits in lesional skin of LV patients is shown as
numbers of positive vessels per high power field. Lesional skin samples of
15 patients were analyzed by immunohistochemistry and visual counting
of positively stained vessels.
individuals homozygous for FcγRIIa–R131 inefficiently phagocy-
tose IgG2-coated bacteria (Bredius et al, 1993; Sanders et al, 1995).
If one postulates that IgG2 is the pathogenic component within
CIC causing vasculitis, the FcγRIIa–R131 allele should be absent
or clearly less frequent in individuals with LV. In other words,
individuals with the FcγRIIa–H131 allele should be more suscept-
ible to LV. We, therefore, sequenced the FcγRIIa gene of patients
and healthy controls to type the two FcγRIIa alleles.
Of 18 patients tested, data of 17 could be evaluated. For
comparison, the FcγRIIa polymorphism was typed in 67 controls,
the gene frequencies for the FcγRIIa–H131 allele were 0.597 and for
the FcγRIIa–R131 allele 0.403. As the expected gene frequencies
(evaluated by the Hardy–Weinberg formula for allele frequencies)
perfectly matched with the observed frequencies seen in the LV
population (Fig 5), the FcγRIIa polymorphism does not appear to
play a part for the precipitation of LV.
Based on the fact that skin microvessels express a single type of
Fc receptor, namely FcγRIIa (Gro¨ger et al, 1996), these findings
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Figure 4. Luminal IgG deposition pre-
cedes endothelial damage. Immunohisto-
chemistry staining of lesional skin of LV patients
with anti-IgG2 antibodies. Images for anti-
IgG3 and IgG4 staining are not shown,
although these latter MoAbs stain fewer vessels
than anti-IgG2 (Fig 3), the staining pattern
was virtually identical to that seen with IgG2.
(a) Shows IgG2 deposition at the luminal
surfaces of a morphologically intact vessel. (b)
A neutrophil is attached to the luminal side of
a vessel with the IgG2 condensed at the
interface between the neutrophil and the endo-
thelial cell. (c) Endothelial cells start to round
up, neutrophils are found within the tissue. (d)
The continuous endothelial lining of the vessel
is disrupted, numerous neutrophils evade the
lumen at this site. (e) The IgG2 is found on
the abluminal side of endothelial cells, which
have rounded up and completely lost cell–cell
contacts. (f) Vascular structures are difficult to
identify, IgG2 is diffusely distributed through-
out the dermis. (g) Normal skin stained with
anti-IgG2, (h) isotype staining, (i) granulation
tissue stained with anti-IgG2. Scale bar: 10 µm.
allow the following conclusions. First, although IgG2 is the
predominant IgG subtype precipitated at endothelial surfaces, it is
apparently not required for fixing CIC to endothelium, because
patients homozygous for FcγRIIa–R131 equally develop LV as
those bearing the FcγRIIa–H131 allele. Second, as IgG1 is virtually
absent in LV lesions and IgG4 does not bind to both FcγRIIa
alleles, these complexes, in addition to IgG2, contain IgG3 in order
to fix to vascular FcγRIIa, at least in persons homozygous for
FcγRIIa–R131. One might thus speculate that CIC, in order to
produce LV, have to contain IgG3. Indirect support for a part for
IgG3 comes from the observation that a cryoglobulin of the IgG3
class, but not an IgG1 switch variant, induces skin LV and
glomerulonephritis when injected into normal mice (Fulpius et al,
1993). Third, IgM is not likely to play an essential part in fixing
CIC to the vessel wall, because vascular IgM deposits were found
in six of our 15 patients only and skin endothelium does not
express Fcµ receptors (data not shown).
Thus, the following scenario for initial events in LV emerges (at
60 GRO¨GER ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 5. The allelic polymorphism of FcgRIIa
does not account for susceptibility to vasculitis.
Sequence analysis of the polymorphic position 519
of the genomic DNA sequence revealed alleles
encoding either for histidine or for arginine at
position 131 of the amino acid sequence of the
FcγRIIa protein. Results from three individuals
being either heterozygous (AG), or homozygous
(A) or (G) for the alleles of the FcγRIIa gene are
shown. Shaded inserts at the right side match the
expected gene frequencies calculated from controls
with the observed frequency in LV patients.
least in patients with postinfectious LV). CIC deposition is the
earliest immune–morphologic detectable alteration within the vessel
wall. They bind to endothelial surfaces by way of FcγRIIa.
CIC, therefore, may directly cause endothelial activation or may
concomitantly bind to neutrophil Fc receptors, thereby bridging
endothelium and neutrophils and multiplying cellular activation.
To elucidate the following steps of cellular activation and to
elucidate the part of complement, in vitro studies employing FcγRIIa
positive endothelial cells and neutrophils together with CIC derived
from LV patients are required. This experimental set-up, however,
is hampered by the fact that in our hands CIC analyzed from the
serum of LV patients predominantly contain IgG1 ! 2 5 3 . 4
(unpublished observation) as opposed to IgG2 . 3 5 4 and no
IgG1 within the lesion. Therefore, CIC used for such experiments
should be ideally those which are deposited within the tissue, but
there is no technique yet available to extract them.
This work was supported by grant 6688 ‘‘Jubila¨umsfonds’’ from the Austrian
National Bank. The authors wish to thank Dr. Nomdo A.C. Westerdaal
(Department of Immunology, University of Hospital Utrecht, The Netherlands) for
the 3T6 cells transfected with either FcγRIIa–R131 or FcγRIIa–H131, Mr
Markus Milacek for his excellent technical assistance and Drs. T. Salletmayr and
C. Alge for assisting in immunohistochemistry staining and visual counting.
REFERENCES
Bonnefoy M, Claudy AL: Prospective study of factors associated with leukocytoclastic
vasculitis. Ann Dermatol Venereol 115:27–32, 1988
Bredius RG, de Vries CE, van Troelstra A, Alphen L, Weening RS, van de Winkel JG,
Out TA: Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B
opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional
hFcγRIIa polymorphism to IgG2. J Immunol 151:1463–1472, 1993
Burgess JK, Lindeman R, Chesterman CN, Chong BH: Single amino acid mutation
of FcγR is associated with the development of heparin-induced
thrombocytopenia. Br J Haematol 91:761–766, 1995
Clynes R, Ravetch JV: Cytotoxic antibodies trigger inflammation through Fc receptors.
Immunity 2:21–26, 1995
Cochrane CG: Mediators of the Arthus and related reactions. Prog Allergy 11:1–35, 1967
Deo YM, Graziano RF, Repp R, van de Winkel JGJ: Clinical significance of IgG Fc
receptors andFcγR-directed immunotherapies. ImmunolToday18:127–135, 1997
Ekenstam EAF, Callen JP: Cutaneous leukocytoclastic vasculitis. Clinical and laboratory
features of 82 patients seen in private practice. Arch Dermatol 120:484–489, 1984
Fulpius T, Spertini F, Reininger L, Izui S: Immunoglobulin heavy chain constant region
determines the pathogenicity and the antigen-binding activity of rheumatoid
factor. Proc Natl Acad Sci USA 90:2345–2349, 1993
Gro¨ger M, Sarmay G, Fiebiger E, Wolff K, Petzelbauer P: Dermal microvascular
endothelial cells express CD32 receptors in vivo and in vitro. J Immunol 156:1549–
1556, 1996
Indik Z, Kelly C, Chien P, Levinson AI, Schreiber AD: Human FcγRII, in the absence
of other FcγRs, mediates a phagocytic signal. J Clin Invest 88:1766–1771, 1991
Kunstfeld R, Lechleitner S, Gro¨ger M, Wolff K, Petzelbauer P: HECA-4521 T Cells
migrate through superficial vascular plexus but not through deep vascular plexus
endothelium. J Invest Dermatol 108:343–348, 1997
Lowry MB, Duchemin AM, Robinson JM, Anderson CL: Functional separation of
pseudopod extension and particle internalization during FcγR-mediated
phagocytosis. J Exp Med 187:161–176, 1998
Matsumura T, Wolff K, Petzelbauer P: Endothelial cell tube formation depends on
cadherin-5 and CD31 interactions with filamentous actin. J Immunol 158:3408–
3416, 1997
McCoombs RP: Systemic ‘‘allergic’’ vasculitis. JAMA 194:1059–1064, 1965
Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA
from human nucleated cells. Nucleic Acids Res 16:1215, 1988
Parren PW, Warmerdam PA, Boeije LC, et al: On the interaction of IgG subclasses with
the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets.
Analysis of a functional polymorphism to human IgG2. J Clin Invest 90:1537–
1546, 1992
Ravetch JV: Fc receptors: rubor redux. Cell 78:553–560, 1994
Sanders LA, Feldman RG, Voorhorst OMM, et al: Human immunoglobulin G (IgG)
Fc receptor IIA (CD32) polymorphismand IgG2-mediatedbacterial phagocytosis
by neutrophils. Infect Immunity 63:73–81, 1995
Sylvestre DL, Ravetch JV: Fc receptors initiate the Arthus reaction: redefining the
inflammatory cascade. Science 265:1095–1098, 1994
